![]() |
![]() |
| Korean J Ophthalmol > Volume 39(3); 2025 > Article |
|
| Study | Country | Sample size (no. of eyes) | Age (yr)* | Sex (no. of patients) | Type of pterygium (size) | Type of surgery | Time after treatment | |
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
| Male | Female | |||||||
| Fong et al. [12] (1998) | Singapore | 123 | 48 | 82 | 41 | Primary | BS technique, conjunctival grafting surgery | 6 mon |
| Vadodaria et al. [7] (2019) | India | 50 | 20-40 | - | - | Grades 1-4 | CAG with and without suture | 3 wk |
| Tomidokoro et al. [14] (2000) | Japan | 163 | 64.6 (39-86) | 60 | 84 | Primary | CAG, AMG | 6 mon |
| Pesudovs and Figueiredo [19] (2006) | Australia | 67 | 53.8 (25-86) | 49 | 13 | Severe pterygium (1-5.9 mm) | Free CAG, adjunctive triamcinolone | 6 mon |
| Barman et al. [18] (2023) | India | 50 | 47 | 33 | 27 | Primary pterygium | Pterygium excision, autologous stem cell grafting placed by suture | 1 mon |
| Ozgurhan et al. [22] (2015) | Turkiye | 88 | 47 (26-60) | 66 | 32 | Primary (group 1, n = 47) and recurrent (group 2, n = 41) | Pterygium excision, CAG transplantation | 12 mon |
| Yilmaz et al. [31] (2008) | Turkiye | 120 | 47.5 | 80 | 40 | - | BS excision with MC, LCA, CAG | 4 mon |
| Roche et al. [25] (2021) | India | 75 | 47 (46-65) | 56 | 19 | Severe and primary (1.25-6 mm) | CAG | 3 mon |
| Deepankar et al. [21] (2016) | India | 50 | - | 32 | 18 | Primary | Pterygium excision and limbal stem cell autograft transplantation | 3 mon |
| Tang et al. [35] (2020) | China | 81 | 62.8 (43-85) | 32 | 49 | Primary (2.75 mm) | Pterygium excision and limbus CAG surgery | 1 mon |
| Kheirkhah et al. [15] (2012) | Iran | 73 | 43.4 (21-67) | 45 | 26 | Primary (2.89 mm) | BS technique, amniotic membrane transplantation, free CAG | 6 mon |
| Kim et al. [28] (2014) | South Korea | 66 | 58.7 | 31 | 35 |
Primary: group A (<2 mm): n = 35 group B (≥2 mm): n = 31 |
CAG technique | 3 mon |
| Jain and Pandey [24] (2020) | India | 64 | 34.16 (18-60) | 40 | 24 | Grade II-IV | Excision with autologous graft surgery | 4 mon |
| Verma et al. [26] (2020) | India | 50 | 52.7 | 35 | 15 |
Severe pterygium: group A (≤2 mm): n = 15 group B (2-4 mm): n = 23 group C (>4 mm): n = 12 |
LCA | 3 mon |
| Kazanci et al. [29] (2022) | Turkiye | 50 | 53 (30-70) | 27 | 23 | Primary and recurrent | Superior (n = 25) and inferior (n = 25) limbal autograft | 6 mon |
| Garg et al. [27] (2019) | India | 71 | 39.69 (20-60) | 40 | 31 | Primary | BS (n = 23), CAG (n = 24), AMG (n = 24) | 3 mon |
| Lawan et al. [10] (2018) | Nigeria | 45 | 28-75 | 21 | 12 | Primary | BS technique with MC | 6 wk |
| Bahar et al. [23] (2004) | Israel | 55 | 59.1 (36-71) | 30 | 24 | Primary | BS technique with MC | 6 mon |
| Pujol et al. [33] (2014) | Spain | 68 | 41.82 (24-65) | 36 | 24 | Primary | LCA with MC (group 1) and without MC (group 2) | 6 mon |
| Chourasia et al. [32] (2014) | India | 50 | 32.54 (20-64) | 26 | 20 | Primary | Pterygium excision with LCA | 6 mon |
| Parajuli and Bajracharya [20] (2019) | Nepal | 61 | 46.11 | 26 | 30 | Primary | Autologous conjunctival graft | 1 mon |
| Niruthisard et al. [34] (2021) | Thailand | 75 | 55.5 (20- 76) | 35 | 40 | Primary or recurrent pterygium (0.3-8 mm) | Pterygium excision | 6 mon |
| Sen et al. [30] (2023) | India | 68 | >18 | 45 | 21 | Primary | Autologous blood technique (group A), suture technique (group B), fibrin glue technique (group C), bridge technique (group D) | 6 mon |
| Study | Before vs. after intervention* | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|||||||||||
| Visual acuity | Astigmatism | WTR | ATR | SE | Corneal SP | Keratometry value | Wavefront aberration | SRI | SAI | ||
|
|
|||||||||||
| K1 | K2 | ||||||||||
| Fong et al. [12] (1998) | - | 0.99 D vs. 0.21 D (p < 0.05) | - | - | - | - | - | - | - | - | - |
| Vadodaria et al. [7] (2019) | - | 1.02 ± 0.89 vs. 0.17 ± 0.26 (p < 0.05) | 58% vs. 32% | 32% vs. 14% | 1.06 ± 1.39 vs. 0.08 ± 0.23 (p < 0.05) | - | 2.55 ± 1.14 vs. 0.6 ± 0.4 (p < 0.05) | - | - | - | - |
| Tomidokoro et al. [14] (2000) | - | 3.8 ± 2.8 vs. 1.0 ± 0.6 (p < 0.05) | - | - | - | 43.6 ± 1.8 vs. 44.9 ± 1.4 (p < 0.05) | - | - | - | 1.0 ± 0.53 vs. 0.7 ± 0.3 (p < 0.05) | 0.94 ± 0.79 vs. 0.50 ± 60.31 (p < 0.05) |
| Pesudovs and Figueiredo [19] (2006) | 0.03 ± 0.17 vs. 0.04 ± 0.17 | Decreased after surgery | - | - | - | - | - | - | 0.94 ± 0.8 μm vs. 0.45 ± 0.3 μm (p < 0.05) | - | - |
| Barman et al. [18] (2023) | 11.04 ± 3.98 vs. 7.80 ± 2.48 (p < 0.05) | p < 0.05 | - | - | - | - | p < 0.05 | p < 0.05 | - | - | - |
| Ozgurhan et al. [22] (2015) |
CDVA (group 1 vs. group 2): 0.63 ± 0.27 vs. 0.53 ± 0.26 (p = 0.07) UCDVA (group 1 vs. group 2): 0.78 ± 0.26 vs. 0.67 ± 0.29 (p = 0.08) |
Before (group 1 vs. group 2): 4.45 ± 4.95 vs. 3.86 ± 3.21 (p = 0.57) After (group 1 vs. group 2): 0.85 ± 0.53 vs. 1.92 ± 1.88 (p > 0.05) |
- | - |
Before (group 1 vs. group 2): 0.30 ± 0.28 vs. 0.35 ± 0.37 (p = 0.48) After (group 1 vs. group 2): 0.27 ± 0.1 vs. 0.29 ± 0.12 (p > 0.71) |
- | Group 1 vs. group 2: 40.1 ± 4.9 vs. 41.5 ± 2.5 (p = 0.16) | Group 1 vs. group 2: 44.6 ± 2.5 vs. 45.3 ± 2.7 (p = 0.43) |
Before (group 1 vs. group 2): 4.51 ± 4.09 vs. 4.56 ± 5.86 (p = 0.96) After (group 1 vs. group 2): 21.13 ± 0.60 vs. 1.82 ± 0.92 (p > 0.05) |
- | - |
| Yilmaz et al. [31] (2008) | - | p < 0.05 | - | - | p > 0.05 | p < 0.05 | - | - | - | - | - |
| Roche et al. [25] (2021) | UCDVA: 0.53 ± 0.03 vs. 0.78 ± 0.03 (p < 0.05) | 2.55 ± 0.36 vs. 1.21 ± 0.2 (p < 0.05) | 64.0% vs. 16.6% | Before: 16% A: - | - | - | - | - | - | - | - |
| Deepankar et al. [21] (2016) | CDVA: 0.54 ± 0.48 vs. 0.69 ± 0.5 (p < 0.05) | 3.12 ± 2.02 vs. 1.43 ± 1.24 (p < 0.05) | 100% | - | - | - | - | - | - | - | - |
| Tang et al. [35] (2020) | - | 4.35 ± 4.24 vs. 1.07 ± 0.9 (p < 0.05) | - | - | - | - | - | - | - | - | - |
| Kheirkhah et al. [15] (2012) | - |
FCA: 3.97 ± 4.49 vs. 1.08 ± 2.05 (p < 0.05) BCA: 0.35 ± 0.39 vs. 0.29 ± 0.21 (p < 0.05) |
43.8% vs. 87.7% | 24.6% vs. 4.1% | - | - | 3.76 ± 3.66 vs. 1.14 ± 1.24 (p < 0.05) | - | - | - | - |
| Kim et al. [28] (2014) | - | 0.69 ± 0.52 vs. 2.72 ± 2.18 (p < 0.05) | 68% | 15% | - | - | Based on 0.5 D: 36% vs. 42% (p < 0.05) | - | - | - | - |
| Jain and Pandey [24] (2020) | BCVA: 0.20 (0.16-0.25) vs. 0.53 (0.50-0.80) (p < 0.05) | 1.37 (1.25-1.93) vs. 0.5 (0.32-0.75) (p < 0.05) | - | - | - | - | 43 (42.5-44) vs. 42.50 (42.5-42.9) (p < 0.05) | 44.25 (43.7-44.5) vs. 42.5 (42.50-43.00) (p < 0.05) | - | - | - |
| Verma et al. [26] (2020) | UCVA: 0.27 ± 0.23 vs. 0.49 ± 0.39 (p < 0.05) | 3.63 ± 2.78 vs. 1.19 ± 1.14 (p < 0.05) | 76% | 8% | - | - | - | - | - | - | - |
| Kazanci et al. [29] (2022) | - |
Superior: 2.51 ± 3.56 vs. 1.04 ± 0.83 (p < 0.05) Inferior: 4.36 ± 3.92 vs. 0.87 ± 0.82 (p < 0.05) |
- | - | - | - |
Superior: 41.9 ± 3.41 vs. 43.02 ± 1.69 (p < 0.05) Inferior: 40.28 ± 4.01 vs. 43.47 ± 1.68 (p < 0.05) |
Superior: 42.84 ± 8.06 vs. 44.14 ± 1.3 (p = 0.91) Inferior: 44.66 ± 1.63 vs. 44.41 ± 1.98 (p = 0.07) |
- |
Superior: 58.8 ± 44.1 vs. 23.52 ± 12.1 Inferior: 76.6 ± 82.3 vs. 20.1 ± 5.75 (p < 0.05) |
Superior: 0.42 ± 0.3 vs. 0.17 ± 0.090 Inferior: 0.5 ± 0.69 vs. 0.2 ± 0.16 (p < 0.05) |
| Garg et al. [27] (2019) | UCVA: 0.56 ± 0.49 vs. 0.32 ± 0.29 (p < 0.05) |
3.47 ± 1.74 vs. 1.10 ± 0.78 (p < 0.05) Decreased in three groups |
- | - | - | - | - | - | - | - | - |
| Lawan et al. [10] (2018) | BCVA: 2.12 ± 1.09 vs. 4.82 ± 2.37 (p < 0.05) | 2.12 ± 1.09 vs. 0.72 ± 0.50 (p < 0.05) | 68% | 28% | - | - | - | - | - | - | - |
| Bahar et al. [23] (2004) | BCVA: 20 / 40 vs. 20 / 25 (p < 0.05) | 3.12 ± 2.43 vs. 2.51 ± 2.50 (p < 0.05) | - | - | - | - | - | - | - | 0.99 ± 0.65 vs. 0.90 ± 0.65 (p > 0.05) | 1.87 ± 1.69 vs. 1.23 ± 1.49 (p > 0.05) |
| Pujol et al. [33] (2014) | - | Group 1: 1.4 ± 1.1 vs. 1.6 ± 1.0 Group 2: 0.9 ± 0.5 vs. 1.1 ± 0.9 (before vs. after, p < 0.05; between groups, p > 0.05) | - | - | - | - | - | - | - | - | - |
| Chourasia et al. [32] (2014) | - | 1.13 D vs. 0.13 D (p < 0.05) | - | - | - | - | - | - | - | - | - |
| Parajuli and Bajracharya [20] (2019) | No change | 2.8 ± 3.9 vs. 1.1 ± 2.2 (p < 0.05) | - | - | - | - | - | - | - | - | - |
| Niruthisard et al. [34] (2021) | - | Majority (73.3%) demonstrated corneal astigma- tic and corneal keratometric stability | 30% | 65% | - | - | - | - | - | - | - |
| Sen et al. [30] (2023) | - | p < 0.05 | - | - | - | - | Before vs. after for groups A and C (p < 0.05) | Before vs. after for group C (p < 0.05) | - | - | - |
WTR = with-the-rule; ATR = against-the-rule; SE = spherical error; Sp = spherical power; K1 = horizontal keratometry; K2 = vertical keratometry; SRI = surface regularity index; SAI = surface asymmetry index; D = diopters; CDVA = corrected distance visual acuity; UCDVA = uncorrected distance visual acuity; FCA = front corneal astigmatism; BCA = back corneal astigmatism; UCVA = uncorrected visual acuity; BCVA = best-corrected visual acuity.
| Study | Recurrence rate (%) | Size pterygium | Outcome |
|---|---|---|---|
| Fong et al. [12] (1998) | - | Astigmatism of 1 D or greater occurred when the pterygium extended more than 3.5 mm past the limbus | Removing a pterygium leads to the correction of the corneal flattening associated with it. |
| Vadodaria et al. [7] (2019) | - |
Before: 2.52 mm (range, 1-4.5 mm) Grade of pterygium was correlated with keratometry value |
Following pterygium removal surgery, most patients experienced no refractive errors, with the exception of a basic myopic refractive error. Specifically, 56% of patients had no refractive errors, while 26% had simple myopic astigmatism. |
| Tomidokoro et al. [14] (2000) | 6.25 | Astigmatism and SP were correlated to pterygium size | The presence of pterygium and its removal have a substantial impact on corneal refraction, affecting SP, astigmatism, asymmetry, and irregularity. |
| Pesudovs and Figueiredo [19] (2006) | - | Pterygium size is correlated to RMS and WFE aberration | Pterygia are linked to WFE distortions, particularly trefoil, but these abnormalities are mostly corrected through surgical intervention. |
| Barman et al. [18] (2023) | - | - | The presence of pterygium affects visual acuity and alters K1 and K2 values, with K1 values showing more variation than K2 values. |
| Ozgurhan et al. [22] (2015) | - | The pterygium size was correlated with all corneal WFE | Group 2 (recurrent) showed higher corneal aberrations than group 1 (primary) after surgery. |
| Yilmaz et al. [31] (2008) | - | - | Pterygium surgery effectively reduces refractive astigmatism and topographic irregularity, but increases SP and steepens the cornea. The MC group shows the highest induced astigmatism, while the LCA group has the least. |
| Roche et al. [25] (2021) | - | The pterygium size was correlated with visual acuity | Three months after the procedure, significant enhancements in visual acuity and reductions in corneal astigmatism induced by pterygium were noted. |
| Deepankar et al. [21] (2016) | - | Astigmatism and SP were correlated to pterygium size | After the pterygium was removed, there was a significant reduction in astigmatism. The average preoperative refractive cylinder diminished depending on the pterygium’s grade. |
| Tang et al. [35] (2020) | - | - | Following pterygium surgery, there was a reduction in corneal astigmatism and an enhancement in the overall corneal refractive power. |
| Kheirkhah et al. [15] (2012) | - | - | Surgical intervention for pterygium led to notable alterations in both the anterior and posterior corneal surfaces. Eyes afflicted with more severe pterygium experienced a greater degree of surgically induced astigmatism. |
| Kim et al. [28] (2014) | - | Astigmatism was correlated to pterygium size | Surgery on a pterygium longer than 2.0 mm resulted in a notable alteration of corneal power. |
| Jain and Pandey [24] (2020) | - | - | Removing a pterygium with an autologous graft significantly decreased keratometric astigmatism caused by the pterygium and markedly enhanced BCVA. |
| Verma et al. [26] (2020) | 0 | Horizontal length of a pterygium was correlated with the preoperative topographic astigmatism | The size of the pterygium is positively correlated with preoperative corneal astigmatism, which decreases following pterygium surgery. |
| Kazanci et al. [29] (2022) | - | - | Pterygium surgery with limbal autograft significantly improves corneal astigmatism. The conjunctiva’s location does not affect the outcome, but using the lower bulbar conjunctiva can be effective when preservation is needed. |
| Garg et al. [27] (2019) | - | Astigmatism was correlated with grade of pterygium | Pterygium removal reduces astigmatism and improves vision. AMG and CAG are more effective than the BS technique. |
| Lawan et al. [10] (2018) | - | - | Surgical removal of pterygium significantly decreases the level of astigmatism it causes and is linked to an enhancement in visual clarity. |
| Bahar et al. [23] (2004) | 7.3 | Preoperative and postoperative astigmatism were both related to the size of the pterygium | Pterygium surgery markedly lowers refractive astigmatism and enhances SRI, SAI, and BCVA. |
| Pujol et al. [33] (2014) | 4.4 | - | For patients with over 1.05 D of preoperative corneal astigmatism, surgery can partially reduce it. Preoperative astigmatism values should be slightly above the threshold to minimize final astigmatism. |
| Chourasia et al. [32] (2014) | 4 | - | Greater lengths and higher vascularity levels were linked to increased pterygium-induced astigmatism. |
| Parajuli and Bajracharya [20] (2019) | - | - | Following pterygium surgery, astigmatism notably decreases, while higher grades of pterygium are associated with an increase in astigmatism. |
| Niruthisard et al. [34] (2021) | - | When the pterygium extended beyond 3.00 mm, it caused a delay in achieving stable corneal astigmatism | Corneal astigmatic stability achieved in 40% and 73% achieved keratometric stability. |
| Sen et al. [30] (2023) | 10 | - | Following the removal of pterygium, using CAG with autologous blood or glue significantly reduces astigmatism caused by pterygium and lowers recurrence rates, all while offering the benefit of a shorter surgery duration. |
D = diopters; SP = spherical power; RMS = root mean square; WFE = wavefront error; K1 = horizontal keratometry; K2 = vertical keratometry; MC = mitomycin C; LCA = limbal-conjunctival autograft; BCVA = best-corrected visual acuity; AMG = amniotic membrane graft; CAG = conjunctival autograft; BS = bare sclera; SRI = surface regularity index; SAI = surface asymmetry index.
| Study | Bias due to confounders | Bias due to the selection of participants | Bias due to the measurement of variables | Bias due to missing data | Incomplete outcome data | Free of selective reporting | Other sources of bias |
|---|---|---|---|---|---|---|---|
| Fong et al. [12] (1998) | No | Yes | No | No | Yes | No | Unclear |
| Vadodaria et al. [7] (2019) | No | Yes | No | No | No | Yes | No |
| Tomidokoro et al. [14] (2000) | No | Yes | No | No | No | Yes | No |
| Pesudovs and Figueiredo [19] (2006) | No | Yes | No | No | No | Yes | No |
| Barman et al. [18] (2023) | No | Yes | No | No | Yes | No | Unclear |
| Ozgurhan et al. [22] (2015) | No | Yes | No | No | No | Yes | No |
| Yilmaz et al. [31] (2008) | No | Yes | No | No | Yes | No | Unclear |
| Roche et al. [25] (2021) | No | Yes | No | No | No | Yes | No |
| Deepankar et al. [21] (2016) | No | Yes | No | No | No | Yes | No |
| Tang et al. [35] (2020) | No | Yes | No | No | No | Yes | No |
| Kheirkhah et al. [15] (2012) | No | Yes | No | No | No | Yes | No |
| Kim et al. [28] (2014) | No | Yes | No | No | No | Yes | No |
| Jain and Pandey [24] (2020) | No | Yes | No | No | No | Yes | No |
| Verma et al. [26] (2020) | No | Yes | No | No | No | Yes | No |
| Kazanci et al. [29] (2022) | No | Yes | No | No | No | Yes | No |
| Garg et al. [27] (2019) | No | Yes | No | No | No | Yes | No |
| Lawan et al. [10] (2018) | No | Yes | No | No | No | Yes | No |
| Bahar et al. [23] (2004) | No | Yes | No | No | No | Yes | No |
| Pujol et al. [33] (2014) | No | Yes | No | No | No | Yes | No |
| Chourasia et al. [32] (2014) | No | Yes | No | No | No | Yes | Unclear |
| Parajuli and Bajracharya [20] (2019) | No | Yes | No | No | No | Yes | No |
| Niruthisard et al. [34] (2021) | No | Yes | No | No | No | Yes | Unclear |
| Sen et al. [30] (2023) | No | Yes | No | No | No | No | No |

![]() |
![]() |